Literature DB >> 34147108

RSF1 in cancer: interactions and functions.

Guiyang Cai1, Qing Yang2, Wei Sun3.   

Abstract

RSF1, remodelling and spacing factor 1, is an important interphase centromere protein and is overexpressed in many types of cancers and correlated with poor overall survival. RSF1 has functions mainly in maintaining chromosome stability, facilitating DNA repair, maintaining the protein homeostasis of RSF1 and suppressing the transcription of some oncogenes when RSF1 protein is expressed at an optimal level; however, RSF1 overexpression facilitates drug resistance and cell cycle checkpoint inhibition to prompt cancer proliferation and survival. The RSF1 expression level and gene background are crucial for RSF1 functions, which may explain why RSF1 has different functions in different cancer types. This review summarizes the functional domains of RSF1, the overexpression status of RSF1 and SNF2H in cancer based on the TCGA and GTEX databases, the cancer-related functions of RSF1 in interacting with H2Aub, HDAC1, CENP-A, PLK1, ATM, CENP-S, SNF2H, HBX, BubR1, cyclin E1, CBP and NF-κB and the potential clinical value of RSF1, which will lay a theoretical foundation for the structural biology study of RSF1 and application of RSF1 inhibitors, truncated RSF1 proteins and SNF2H inhibitors in the treatment of RSF1-overexpressing tumours.

Entities:  

Keywords:  CENP-A; H2Aub; NF-κB; PLK1; RSF1; SNF2H

Year:  2021        PMID: 34147108     DOI: 10.1186/s12935-021-02012-9

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  91 in total

1.  Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma.

Authors:  Fu-Min Fang; Chien-Feng Li; Hsuan-Ying Huang; Ming-Tsong Lai; Chih-Mei Chen; I-Wen Chiu; Tian-Li Wang; Fuu-Jen Tsai; Ie-Ming Shih; Jim Jinn-Chyuan Sheu
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Rsf-1 is overexpressed in non-small cell lung cancers and regulates cyclinD1 expression and ERK activity.

Authors:  Qingchang Li; Qianze Dong; Enhua Wang
Journal:  Biochem Biophys Res Commun       Date:  2012-02-24       Impact factor: 3.575

3.  Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma.

Authors:  Tsui-Lien Mao; Chih-Yi Hsu; May J Yen; Blake Gilks; Jim Jinn-Chyuan Sheu; Edward Gabrielson; Russell Vang; Leslie Cope; Robert J Kurman; Tian-Li Wang; Ie-Ming Shih
Journal:  Hum Pathol       Date:  2006-07-07       Impact factor: 3.466

4.  Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma.

Authors:  Ie-Ming Shih; Jim Jinn-Chyuan Sheu; Antonio Santillan; Kentaro Nakayama; M Jim Yen; Robert E Bristow; Russell Vang; Giovanni Parmigiani; Robert J Kurman; Claes G Trope; Ben Davidson; Tian-Li Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

5.  Structural Basis of Nucleosome Recognition and Modulation.

Authors:  Rajivgandhi Sundaram; Dileep Vasudevan
Journal:  Bioessays       Date:  2020-06-22       Impact factor: 4.345

6.  Rsf-1/HBXAP overexpression is associated with disease-specific survival of patients with gallbladder carcinoma.

Authors:  Tzu-Ju Chen; Shun-Chen Huang; Hsuan-Ying Huang; Yu-Ching Wei; Chien-Feng Li
Journal:  APMIS       Date:  2011-09-22       Impact factor: 3.205

7.  Mammalian ISWI and SWI/SNF selectively mediate binding of distinct transcription factors.

Authors:  Darko Barisic; Michael B Stadler; Mario Iurlaro; Dirk Schübeler
Journal:  Nature       Date:  2019-04-17       Impact factor: 49.962

8.  Constructing arrays of nucleosome positioning sequences using Gibson Assembly for single-molecule studies.

Authors:  Graeme A King; Erwin J G Peterman; Gijs J L Wuite; Dian Spakman
Journal:  Sci Rep       Date:  2020-06-18       Impact factor: 4.379

Review 9.  Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancer.

Authors:  Adrian P Bracken; Gerard L Brien; C Peter Verrijzer
Journal:  Genes Dev       Date:  2019-05-23       Impact factor: 11.361

10.  Cryo-EM structures of remodeler-nucleosome intermediates suggest allosteric control through the nucleosome.

Authors:  Jean Paul Armache; Nathan Gamarra; Stephanie L Johnson; John D Leonard; Shenping Wu; Geeta J Narlikar; Yifan Cheng
Journal:  Elife       Date:  2019-06-18       Impact factor: 8.140

View more
  2 in total

1.  RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4+ T-cell-dependent antitumor immunity.

Authors:  Zhuo Zhang; Lin Luo; Chuan Xing; Yu Chen; Peng Xu; Mao Li; Ling Zeng; Chao Li; Sadashib Ghosh; Deborah Della Manna; Tim Townes; William J Britt; Narendra Wajapeyee; Barry P Sleckman; Zechen Chong; Jianmei Wu Leavenworth; Eddy S Yang
Journal:  Nat Cancer       Date:  2021-10-22

Review 2.  CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer.

Authors:  Mostafa Vaghari-Tabari; Parisa Hassanpour; Fatemeh Sadeghsoltani; Faezeh Malakoti; Forough Alemi; Durdi Qujeq; Zatollah Asemi; Bahman Yousefi
Journal:  Cell Mol Biol Lett       Date:  2022-06-17       Impact factor: 8.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.